Sandoz

Sandoz is a global leader in generic and biosimilar medicines. Novartis' generic medicines company, Sandoz, is a global leader in generics. Sandoz is a renowned leader with a reputation for high quality, with a history spanning more than 120 years. Following the loss of patent protection, they have taken a strategic and customer-focused strategy to discovering, producing, and selling cheap medications. As a result, they have become one of the two most well-known generics firms in the world.

90 percent of the world's population has access to their medications. Sandoz also helps to healthcare system stability by providing a diverse range of high-quality, cheap medications. They provide large savings that can be utilized to support more expensive innovative medications, hence promoting further pharmaceutical research. Their global development and manufacturing, as well as global commercialization

Their worldwide portfolio consists of roughly 1,000 compounds that cover all key therapeutic categories and generated USD 9.7 billion in sales in 2019. Their products are used by about 500 million people.

Founded: 1886

Address: Basel, Basel-Stadt
Type: Public Company

Industries: Pharmaceuticals

Website: https://www.sandoz.com/